Biogen plunks down $1B in cash to expand neuro drug pact with Ionis
April 20, 2018 at 09:35 AM EDT
The companies previously collaborated to develop a treatment for a rare infant disorder that won FDA approval in December 2016. They will pursue similar drugs under the deal announced Friday.
